Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 405.80K | 436.10K | 512.50K | 594.80K | 676.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 405.80K | 436.10K | 512.50K | 594.80K | 676.20K |
| Cost of Revenue | 151.30K | 137.30K | 184.00K | 198.40K | 230.00K |
| Gross Profit | 254.40K | 298.70K | 328.50K | 396.40K | 446.20K |
| SG&A Expenses | 1.09M | 1.12M | 1.11M | 1.28M | 2.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.25M | 1.26M | 1.30M | 1.48M | 2.44M |
| Operating Income | -839.80K | -820.80K | -783.60K | -887.00K | -1.77M |
| Income Before Tax | -1.30M | -1.32M | -1.23M | -1.39M | 2.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.30 | -1.32 | -1.23 | -1.39 | 2.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.30M | -1.32M | -1.23M | -1.39M | 2.08M |
| EBIT | -839.80K | -820.80K | -783.60K | -887.00K | -1.77M |
| EBITDA | -832.30K | -809.70K | -769.00K | -868.80K | -1.75M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 30.58B | 30.54B | 30.48B | 30.43B | 30.41B |
| Average Diluted Shares Outstanding | 30.58B | 30.54B | 30.48B | 30.43B | 53.88B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |